CAS: 122-05-4; Pyrazine-2,5-Dicarboxylic Acid

相似化合物

205692-63-3 710322-57-9 1211533-09-3

上下游产品

2,5-dimethyl-pyrazine 2-pyrazylcarboxylic acid bromopyruvic acid dimethyl Pyrazine-2,5-dicarboxylatedimethyl Pyrazine-2,5-dicarboxylate 1,4-pyrazine 2-pyrazylcarboxylic acid methylammonium carbonate

📜吡嗪-2,5-二羧酸二甲酯置于sodium Azide,硫酸,三氯乙酸体系中,化学反应生成2,5-吡嗪二羧酸
参考文献:Syntheses In The Pyrazine Series; Synthesis Of 2,5-Diaminopyrazine1
标题:Syntheses In The Pyrazine Series; Synthesis Of 2,5-Diaminopyrazine1
摘要:
Doi:10.1021/ja01148A066

专利信息

专利号:US-2022089618-A1
优先权日:2019-01-29
标题:Solid-State Synthesis Of Precursors Of Metal-Organic Frameworks
发明人：MAJANO GERARDO J; FALKOWSKI JOSEPH M
权利人:EXXONMOBIL RES & ENG CO
摘要:Metal-organic frameworks (MOFs) are highly porous entities comprising a multidentate ligand coordinated to multiple metal atoms, typically as a coordination polymer. MOFs are usually produced from a solvent in powder form under hydrothermal or solvothermal synthesis conditions. Alternately, powder-form precursors of MOFs may be formed by milling or mulling a substantially solid mixture of a metal salt and a multidentate organic ligand, optionally in the presence of a small amount of a solvent. The powder-form precursors may then undergo heating, typically in the absence of applied shear, to produce the corresponding MOF. Mulling may be differentiated from milling at least in that mulling applies to the substantially solid mixture at a non-constant pressure and milling applies a constant pressure while forming the powder-form precursor. In some cases, mulling may promote more effective formation of the powder-form precursor compared to milling.

专利号:US-10737239-B2
优先权日:2015-11-27
标题 :Ultrafast high space-time-yield synthesis of metal-organic frameworks
发明人：BURCKHART JULIA; MARX STEFAN; ARNOLD LENA; HOFMANN CLAUS; Müller Ulrich
权利人:BASF SE
摘要:The invention relates to a process for the preparation of metal-organic frameworks (MOFs) in form of a homogenous powder, and a process wherein the metal-organic framework is molded into shaped bodies.

专利号:US-11739112-B2
优先权日:2017-02-02
标 题:Low temperature process for the synthesis of MOF carboxylate nanoparticles
发明人：PANCHAL MONIK; NOUAR FARID; SERRE CHRISTIAN; BENZAQUI MARVIN; SENE SAAD; STEUNOU NATHALIE; GIMÉNEZ MARQUÉS MONICA
权利人:CENTRE NAT RECH SCIENT; UNIV DE VERSAILLES—SAINT QUENTIN EN YVELINES
摘要:The present invention relates to low temperature process for preparing nanoparticles of porous crystalline Fe-, Al- or Ti-based MOF carboxylate materials with low polydispersity index, and uses thereof, particularly as catalyst support for carrying out heterogeneously catalyzed chemical reactions, or as gas storage/separation/purification material, or as matrix for encapsulating active principles (medicine, cosmetics).

专利号:US-5091066-A
优先权日:1987-11-19
标 题 :Electrochemical synthesis of 2-methyl-5-pyrazinoic acid
发明人：FOA MARCO; FORLINI FABRIZIO; GATTI NORBERTO; BORSOTTI GIAMPIERO
权利人:MINI RICERCA SCIENT TECNOLOG
摘要:There is disclosed a process for the preparation of 2-methyl-5-pyrazinoic acid consisting of electrochemically oxidizing a compound having formula: ##STR1## wherein X is --OH, Cl, Br, --O--CO--R, --O--SO 2 --R, in which R is a C 1 -C 5 alkyl radical, optionally substituted with F or Cl, or it is a C 6 -C 12 aryl radical, in an aqueous alkaline medium, at a temperature ranging from 20° C. to 90° C., using anodes coated with nickel oxide-hydroxide.

专利号:US-2018333696-A1
优先权日:2015-11-27
标题:Ultrafast high space-time-yield synthesis of metal-organic frameworks

专利号:WO-9729091-A1
优先权日:1996-02-09
标题:Balanol analogues
发明人：NIELSEN JOHN; LYNGSOE LARS OLE
权利人:AUDA PHARMACEUTICALS APS; NIELSEN JOHN; LYNGSOE LARS OLE
摘要:The present invention relates to a solid phase methodology for the preparation of a combinatorial library of structural analogues of the natural product balanol (ophiocordin, azepinostatin), which is a protein kinase C (PKC) and protein kinase A (PKA) inhibitor. The method comprises solid-phase synthesis of the analog variants of balanol whereby a high molecular diversity is introduced. The synthetic scheme is based on a retrosynthetic analysis of the native structure which revealed three main building blocks suitable as templates for modification. The dicarboxy-functional moiety can be immobilised to the polymer support either as the monoallyl ester or as the internal anhydride. The libraries produced by the method are especially suited for high throughput screening of potential drug candidates for the treatment of mammals, especially humans.